23 diciembre 2014
A novel pre-operative drug therapy reduces antibodies in kidney patients with greater success than with traditional methods, with the potential to increase the patients’ candidacy for kidney transplantation and decrease the likelihood of organ rejection. These are the findings of a three-year clinical trial.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/hl3tk8XWluQ/141223161125.htm
